Nov-02-20 Upgrade UBS
Neutral → Buy
$210
Oct-30-20 Upgrade JP Morgan
Underweight → Neutral
$165
Oct-27-20 Upgrade BofA Securities
Underperform → Neutral
$186
Aug-07-20 Downgrade Morgan Stanley
Overweight → Equal-Weight
Jun-17-20 Upgrade Morgan Stanley
Equal-Weight → Overweight
May-01-20 Upgrade Oppenheimer
Perform → Outperform
$200
May-01-20 Downgrade JP Morgan
Neutral → Underweight
Feb-18-20 Downgrade Morgan Stanley
Overweight → Equal-Weight
Feb-03-20 Initiated CLSA
Underperform
Jan-31-20 Downgrade UBS
Buy → Neutral
$150 → $174
Jan-10-20 Initiated Oppenheimer
Perform
Nov-22-19 Initiated KeyBanc Capital Markets
Sector Weight
Jul-29-19 Upgrade UBS
Neutral → Buy
$122 → $140
Jul-16-19 Downgrade UBS
Buy → Neutral
May-06-19 Upgrade UBS
Neutral → Buy
$109 → $119
Apr-18-19 Upgrade JP Morgan
Underweight → Neutral
$95
Jan-25-19 Downgrade JP Morgan
Neutral → Underweight
Jan-25-19 Downgrade Goldman
Buy → Neutral
Oct-26-18 Upgrade Credit Suisse
Neutral → Outperform
Jul-02-18 Initiated Goldman
Buy
Feb-10-21 05:43AM Feb-05-21 11:40AM Feb-03-21 11:06AM Feb-02-21 09:08AM Jan-29-21 09:59AM 07:10AM 01:31AM Jan-28-21 05:25PM 05:14PM 04:05PM Jan-27-21 10:15AM Jan-26-21 01:06PM Jan-22-21 06:35AM Jan-18-21 06:54AM Jan-14-21 11:40AM Jan-07-21 04:05PM Jan-05-21 09:00AM Jan-04-21 08:46AM Dec-30-20 09:57AM Dec-25-20 04:17AM Dec-23-20 03:18PM Dec-21-20 09:33AM 08:59AM Dec-18-20 10:15AM Dec-16-20 09:07AM Dec-15-20 08:46AM Dec-09-20 09:30AM 08:18AM Dec-08-20 10:12AM Dec-07-20 09:53AM 07:30AM Investor's Business Daily
Dec-04-20 11:10AM Dec-03-20 09:31AM 08:37AM Dec-02-20 10:45AM 03:57AM Dec-01-20 10:52AM Nov-30-20 01:44PM Nov-27-20 11:30AM Nov-26-20 09:06AM Nov-25-20 08:59AM Nov-24-20 11:13AM 09:16AM Nov-23-20 03:48PM Nov-19-20 11:08AM 09:27AM 09:16AM Nov-17-20 10:13AM 10:03AM Nov-12-20 08:46AM Nov-11-20 08:11AM Nov-09-20 02:11PM Nov-06-20 08:08AM Nov-05-20 11:30AM 12:06AM Nov-03-20 09:00AM Nov-02-20 01:07PM Investor's Business Daily
10:55AM Oct-30-20 03:31AM Oct-29-20 06:05PM 04:05PM Oct-28-20 11:40AM 09:53AM 08:30AM Oct-26-20 12:10PM 09:38AM Oct-22-20 12:33PM Oct-19-20 06:50PM 01:28PM 08:00AM Investor's Business Daily
Oct-16-20 10:58AM Oct-15-20 12:57PM 11:30AM 09:14AM Oct-14-20 08:06AM Oct-09-20 08:23AM Oct-08-20 04:05PM Oct-06-20 09:01AM Oct-01-20 01:40PM Sep-29-20 06:47PM 04:35PM Sep-24-20 08:00AM Investor's Business Daily
Sep-23-20 10:59AM 10:41AM Sep-09-20 09:00AM Sep-04-20 11:31AM 07:11AM Sep-02-20 08:11AM Sep-01-20 09:00AM Aug-28-20 10:10AM Aug-26-20 08:00AM Aug-18-20 09:44AM Aug-14-20 05:48AM 03:48AM 02:48AM 12:48AM Aug-13-20 11:48PM 05:48PM 04:33PM Aug-11-20 10:00AM
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
TAYLOR RONALD R Director Feb 19 Sale 200.14 4,000 800,564 18,769 Feb 22 11:48 AM Douglas Robert Andrew President and COO ResMed Inc. Feb 16 Sale 200.46 998 200,059 212,452 Feb 17 04:47 PM Sandercock Brett Chief Financial Officer Feb 10 Sale 201.37 2,500 503,425 99,922 Feb 11 04:45 PM PENDARVIS DAVID Chief Administrative Officer Feb 03 Sale 204.42 1,487 303,973 132,268 Feb 05 01:11 PM Hollingshead James President, Sleep Business Feb 01 Sale 200.18 2,400 480,437 87,846 Feb 02 06:59 PM Sodhi Rajwant President, SaaS Business Feb 01 Sale 203.76 1,500 305,640 33,088 Feb 02 01:28 PM Douglas Robert Andrew President and COO ResMed Inc. Jan 15 Sale 212.86 938 199,663 213,450 Jan 19 05:24 PM Sandercock Brett Chief Financial Officer Jan 11 Sale 218.70 2,500 546,750 100,600 Jan 12 04:11 PM Hollingshead James President, Sleep Business Jan 04 Sale 211.09 2,400 506,614 88,333 Jan 05 04:52 PM PENDARVIS DAVID Chief Administrative Officer Jan 04 Sale 213.24 1,487 317,088 132,207 Jan 05 04:50 PM Sodhi Rajwant President, SaaS Business Jan 04 Sale 213.24 1,500 319,860 32,675 Jan 05 12:45 PM Douglas Robert Andrew President and COO ResMed Inc. Dec 15 Sale 207.80 970 201,566 214,388 Dec 16 02:58 PM Sandercock Brett Chief Financial Officer Dec 10 Sale 211.06 2,500 527,650 103,100 Dec 14 12:43 PM PENDARVIS DAVID Chief Administrative Officer Dec 03 Sale 208.36 1,487 309,831 133,694 Dec 07 12:41 PM Hollingshead James President, Sleep Business Dec 01 Sale 210.97 2,400 506,330 90,733 Dec 01 07:37 PM Sodhi Rajwant President, SaaS Business Dec 01 Sale 210.46 1,500 315,690 34,175 Dec 02 05:57 PM Douglas Robert Andrew President and COO ResMed Inc. Nov 24 Sale 211.00 955 201,505 215,836 Nov 25 11:50 AM Sandercock Brett Chief Financial Officer Nov 24 Sale 211.00 5,000 1,055,000 105,600 Nov 25 06:01 PM PENDARVIS DAVID Chief Administrative Officer Nov 20 Option Exercise 84.98 1,176 99,936 145,181 Nov 24 01:31 PM Leong Justin President, Asia Latin America Nov 05 Option Exercise 57.76 7,740 447,062 33,126 Nov 13 09:03 PM Leong Justin President, Asia Latin America Nov 05 Sale 211.36 7,740 1,635,926 25,386 Nov 13 09:03 PM PENDARVIS DAVID Chief Administrative Officer Nov 03 Option Exercise 57.76 5,918 341,824 142,046 Nov 05 02:01 PM PENDARVIS DAVID Chief Administrative Officer Nov 03 Sale 201.14 5,918 1,190,364 136,128 Nov 05 02:01 PM Sodhi Rajwant President, SaaS Business Nov 02 Sale 195.16 1,500 292,740 31,089 Nov 03 03:36 PM Hollingshead James President, Sleep Business Nov 02 Sale 195.00 2,400 467,996 87,602 Nov 03 07:54 PM Douglas Robert Andrew President and COO ResMed Inc. Oct 15 Sale 176.72 1,125 198,810 182,313 Oct 19 04:04 PM Sandercock Brett Chief Financial Officer Oct 15 Sale 176.72 2,500 441,800 84,275 Oct 19 05:20 PM PENDARVIS DAVID Chief Administrative Officer Oct 05 Option Exercise 57.76 5,919 341,881 142,047 Oct 06 06:08 PM PENDARVIS DAVID Chief Administrative Officer Oct 05 Sale 170.07 5,919 1,006,621 136,128 Oct 06 06:08 PM Sodhi Rajwant President, SaaS Business Oct 01 Sale 172.84 1,500 259,260 32,589 Oct 02 04:46 PM Hollingshead James President, Sleep Business Oct 01 Sale 170.43 2,400 409,023 90,002 Oct 02 04:44 PM Sandercock Brett Chief Financial Officer Sep 15 Sale 175.49 2,500 438,725 86,775 Sep 16 06:35 PM Douglas Robert Andrew President and COO ResMed Inc. Sep 15 Sale 175.49 1,147 201,287 183,438 Sep 16 05:01 PM PENDARVIS DAVID Chief Administrative Officer Sep 03 Option Exercise 57.76 5,919 341,881 142,047 Sep 04 05:00 PM PENDARVIS DAVID Chief Administrative Officer Sep 03 Sale 177.52 5,919 1,050,714 136,128 Sep 04 05:00 PM Hollingshead James President, Sleep Business Sep 01 Sale 202.02 2,400 484,854 92,402 Sep 02 05:42 PM Sodhi Rajwant President, SaaS Business Sep 01 Sale 181.00 1,500 271,500 34,089 Sep 02 04:14 PM Douglas Robert Andrew President and COO ResMed Inc. Aug 17 Sale 177.55 1,132 200,987 184,585 Aug 18 02:24 PM Sandercock Brett Chief Financial Officer Aug 17 Sale 177.55 2,500 443,875 89,275 Aug 19 12:34 PM PENDARVIS DAVID Chief Administrative Officer Aug 03 Option Exercise 57.76 5,919 341,881 139,081 Aug 04 08:01 PM PENDARVIS DAVID Chief Administrative Officer Aug 03 Sale 201.99 5,919 1,195,593 133,162 Aug 04 08:01 PM Sodhi Rajwant President, SaaS Business Aug 03 Sale 200.06 1,500 300,090 28,261 Aug 04 05:13 PM Hollingshead James President, Sleep Business Aug 03 Sale 202.02 2,400 484,854 87,474 Aug 04 05:32 PM Sandercock Brett Chief Financial Officer Jul 15 Sale 196.98 2,500 492,450 84,796 Jul 17 09:26 PM Douglas Robert Andrew President and COO ResMed Inc. Jul 15 Sale 196.98 1,026 202,101 185,717 Jul 17 11:27 AM PENDARVIS DAVID Chief Administrative Officer Jul 06 Option Exercise 57.76 5,919 341,881 139,861 Jul 07 03:14 PM PENDARVIS DAVID Chief Administrative Officer Jul 06 Sale 194.64 5,919 1,152,090 133,942 Jul 07 03:14 PM Hollingshead James President, Sleep Business Jul 01 Sale 189.63 2,400 455,112 89,874 Jul 06 11:14 AM Sodhi Rajwant President, SaaS Business Jul 01 Sale 189.49 1,500 284,235 29,761 Jul 02 02:15 PM Douglas Robert Andrew President and COO ResMed Inc. Jun 15 Sale 158.79 1,245 197,694 186,743 Jun 16 07:45 PM Sandercock Brett Chief Financial Officer Jun 15 Sale 158.79 2,500 396,975 87,296 Jun 16 07:43 PM PENDARVIS DAVID Chief Administrative Officer Jun 03 Option Exercise 57.76 5,919 341,881 136,322 Jun 05 12:32 PM PENDARVIS DAVID Chief Administrative Officer Jun 03 Sale 160.61 5,919 950,660 130,403 Jun 05 12:32 PM Sodhi Rajwant President, SaaS Business Jun 01 Sale 160.13 1,500 240,195 31,261 Jun 02 06:22 PM Hollingshead James President, Sleep Business Jun 01 Sale 160.13 1,200 192,156 92,274 Jun 02 07:46 PM Douglas Robert Andrew President and COO ResMed Inc. May 15 Sale 162.05 1,228 198,997 187,988 May 19 12:55 PM Sandercock Brett Chief Financial Officer May 15 Sale 162.05 2,500 405,125 89,796 May 19 10:17 AM PENDARVIS DAVID Chief Administrative Officer May 04 Option Exercise 58.24 4,737 275,883 135,379 May 06 04:31 PM PENDARVIS DAVID Chief Administrative Officer May 04 Sale 155.06 4,737 734,515 130,642 May 06 04:31 PM Sodhi Rajwant President, SaaS Business May 01 Sale 164.00 1,500 246,000 32,670 May 05 12:56 PM Hollingshead James President, Sleep Business May 01 Sale 164.00 1,200 196,800 93,365 May 05 12:44 PM Douglas Robert Andrew President and COO ResMed Inc. Apr 15 Sale 159.03 1,222 194,335 189,216 Apr 16 07:13 PM Sandercock Brett Chief Financial Officer Apr 15 Sale 159.03 2,500 397,575 92,211 Apr 16 07:00 PM PENDARVIS DAVID Chief Administrative Officer Apr 03 Option Exercise 58.24 4,739 275,999 135,303 Apr 06 08:38 PM PENDARVIS DAVID Chief Administrative Officer Apr 03 Sale 152.63 4,739 723,303 130,564 Apr 06 08:38 PM Hollingshead James President, Sleep Business Apr 02 Sale 150.00 1,200 180,000 94,565 Apr 03 04:25 PM Sodhi Rajwant President, SaaS Business Apr 01 Sale 140.73 1,500 211,095 34,170 Apr 03 02:46 PM Sandercock Brett Chief Financial Officer Mar 16 Sale 137.49 2,500 343,725 94,711 Mar 17 05:18 PM Douglas Robert Andrew President and COO ResMed Inc. Mar 16 Sale 137.49 1,336 183,687 190,438 Mar 17 05:16 PM PENDARVIS DAVID Chief Administrative Officer Mar 03 Option Exercise 58.24 4,739 275,999 135,303 Mar 05 02:33 PM PENDARVIS DAVID Chief Administrative Officer Mar 03 Sale 166.65 4,739 789,757 130,564 Mar 05 02:33 PM Sodhi Rajwant President, SaaS Business Mar 02 Sale 160.50 1,500 240,750 35,670 Mar 03 02:31 PM Burt Carol Director Mar 02 Sale 164.90 10,000 1,648,954 13,478 Mar 03 05:19 PM Hollingshead James President, Sleep Business Mar 02 Sale 160.50 1,200 192,600 95,765 Mar 03 04:15 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
